This summary of 510(k) safety and effectiveness information is being submitted in accordance with the requirements of 21 CFR 807.92.

The Assigned 510(k) number is _k103230

# Submitter's Identification

Bestgen Biotech Corporation 7F., No.186, Jian-Yi Rd., 235, Jung-He City, Taipei, Taiwan

Correspondence:   
Steven Shen   
Q.A./ Regulatory Manager   
Tel: +886-2-8227-2188 Ext 211   
Fax: +886-2-8227-2178   
E-mail: stevenshen@mail.bestgen.com.tw

# Device Name

Proprietary name: AP-3000 and AP-3000multi Blood Glucose Monitoring System Regulatory information:

A. Regulation section: 21 CFR Section 862.1345 Glucose Test System 21 CFR Section 862.1660, Quality Control Material   
B Classification: Class II for 862.1345 Class I for 862.1660   
C. Product Code: CGA, Glucose Oxidase, Glucose NBW, System, Test, Blood Glucose, Over The Counter JJX, Quality Control Material (assayed and unassayed)   
D. Panel: Chemistry (75)

# Intended Use

# 3.1 AP-3000 Blood Glucose Monitoring System

T -00 Bloo Gluc oniysteneuaativeauent u th) or  tstg by perns with diabetes athome.TheA-3 Blood Gucose Moniorg Sstis u g a and is not intended for use on neonates.

T with diabetes at home.AP-3000 Blood Glucose Test Strips must be used with the AP-300 Meter. The AP-3000 per hould t ar  oten e  e diabetes mellitus, and is not intended for use on neonates.

T  Bloiv y p ibe o0Bo GucT rshe-B It s u yuses nouonys y a  pat  n intended for the diagnosis of or screening or diabetes mellitus, and is not intended for use on neonates.

MAOR Level /evel Cn Solun   i -300eten-30 Boo Gu quality control check to verify the accuracy of blood glucose test results.

# 3.2 AP-3000multi Blood Glucose Monitoring System

The AP-3000multi Blood Glucose Monitoring System is intended or use n the quantitative measurement of h  st per iabeBloo  Mnys heala et  an mnior theeivenes of abe controlTisst isyusw and is not intended for use on neonates.

T-0ulMe untiveanpi persons with diabetes. AP-3000muti Blood Glucose Test Strips must be used with the AP-3000multi Meter. AP-300multi Meter is intended for testing outside the body in vitro diagnostic use). It is intended for upa allti screening for diabetes mellitus, and is not intended for use on neonates.

T -uBlooGuco ri ten quantatveamenlu p  o tr e st y pers with iabes-0uBlooGucosTt ris mustse wi te AuMeteA-3u Bloo Glucoeest Strips eteertestutsiehe body pa intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates.

MAJOR Level I/Level I Control Solution s or use with AP-300mut eter ndAP-3000mul Blood Gluco Test Strips as a quality control check to verify the accuracy of blood glucose test results.

# Device Description

T  Blo Guc Mys nsTe prut hav been d  proven owor ethr  sys urao uUA-00 s s n MA c  -30 Bloo Gu Monitoring System.

Th AP-mul Bloo Glucoe Mong Syste consist  threea products:he ete st , an se  avbe  p  o   ss l uc susUsen-3u  i n MA cn luwihe -i Blood Glucose Monitoring System.

# 5.Substantial Equivalence Information

A. Predicate device name: AP-1000 Blood Glucose Monitoring System

B. Predicate K number: k090389

C. Comparison with predicate:   
The new device of. AP-3000/AP-3000multi Blood Glucose Monitoring System has the following   
similarities to the predicate device:

<table><tr><td rowspan=1 colspan=3>Similarities</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device(AP-3000/AP-3000multi BGMS)</td><td rowspan=1 colspan=1>Predicate(AP-1000 BGMS, k090389)</td></tr><tr><td rowspan=1 colspan=1>Detection Method</td><td rowspan=1 colspan=1>Amperometry</td><td rowspan=1 colspan=1>Amperometry</td></tr><tr><td rowspan=1 colspan=1>Enzyme</td><td rowspan=1 colspan=1>Glucose Oxidase(Aspergillus niger)</td><td rowspan=1 colspan=1>Glucose Oxidase(Aspergillus niger)</td></tr><tr><td rowspan=1 colspan=1>Test Range</td><td rowspan=1 colspan=1>.20-600 mg/dL</td><td rowspan=1 colspan=1>20-600 mg/dL</td></tr><tr><td rowspan=1 colspan=1>Temperature Range</td><td rowspan=1 colspan=1>50~ 104°F (10~40C)</td><td rowspan=1 colspan=1>50~ 104°F (10~ 40C)</td></tr><tr><td rowspan=1 colspan=1>Open Use Time (Strip)</td><td rowspan=1 colspan=1>90 days</td><td rowspan=1 colspan=1>90 days</td></tr><tr><td rowspan=1 colspan=1>Coding</td><td rowspan=1 colspan=1>Internal Code Selection</td><td rowspan=1 colspan=1>Internal Code Selection</td></tr></table>

<table><tr><td rowspan=1 colspan=3>Differences</td></tr><tr><td rowspan=1 colspan=1>Item</td><td rowspan=1 colspan=1>Device(AP-3000/AP-3000multi BGMS)</td><td rowspan=1 colspan=1>Predicate(AP-1000 BGMS, k090389)</td></tr><tr><td rowspan=1 colspan=1>Meter Size</td><td rowspan=1 colspan=1>55mm x 88mm x26mm</td><td rowspan=1 colspan=1>54mm x 93mm x 16mm</td></tr><tr><td rowspan=1 colspan=1>Meter Weight</td><td rowspan=1 colspan=1>65 g (with battery)</td><td rowspan=1 colspan=1>53 g (with battery)</td></tr><tr><td rowspan=1 colspan=1>Strip Ejection</td><td rowspan=1 colspan=1>Yes                     </td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>LCD with Backlight</td><td rowspan=1 colspan=1>Yes</td><td rowspan=1 colspan=1>No</td></tr><tr><td rowspan=1 colspan=1>Memory Capability</td><td rowspan=1 colspan=1>488 measurements</td><td rowspan=1 colspan=1>960 measurements</td></tr><tr><td rowspan=1 colspan=1>Power</td><td rowspan=1 colspan=1>Two AAA batteries</td><td rowspan=1 colspan=1>One CR2032 3V lithium battery</td></tr><tr><td rowspan=1 colspan=1>Humidity Range</td><td rowspan=1 colspan=1>&lt;85%</td><td rowspan=1 colspan=1>20~80%</td></tr><tr><td rowspan=1 colspan=1>Testing Time</td><td rowspan=1 colspan=1>7 seconds</td><td rowspan=1 colspan=1>6 seconds</td></tr><tr><td rowspan=1 colspan=1>Sample Volume</td><td rowspan=1 colspan=1>0.7 μL</td><td rowspan=1 colspan=1>0.6 μL</td></tr><tr><td rowspan=1 colspan=1>Sample Source</td><td rowspan=1 colspan=1>The glucose concentration ismeasured with quantitativecapillary whole blood from thefingertip, palm, forearm, upper fingertip.arm, calf, and thigh.</td><td rowspan=1 colspan=1>The glucose concentration ismeasured with quantitativecapillary whole blood from the</td></tr><tr><td rowspan=1 colspan=1>HCT Range</td><td rowspan=1 colspan=1>J20-60%</td><td rowspan=1 colspan=1>30-55%</td></tr></table>

# Test Principle

Tll using glucose oxidase.

# Performance Characteristics

The performance of AP-3000/AP-3000multi Blood Glucose Monitoring System was studied in the laboratory and in clinical settings by healthcare professionals and lay users. The studis demonstrated that the performance of this system meets its intended use.

# 8. Conclusion

nAAu u System is substantially equivalent to the predicate AP-1000 Blood Glucose Monitoring System.

Bestgen Biotech Corporation c/o Mr. Steven Shen Quality Assurance Manager 7F., No. 186, Jian-Yi Road, Jung-He City Taipei, Taiwan, 235, ROC

Re: k103230 Trade Name: AP-3000 Blood Glucose Monitoring System AP-3000multi Blood Glucose Monitoring System Regulation Number: 21 CFR $\ S 8 6 2 . 1 3 4 5$ EY Regulation Name: Glucose test system Regulatory Class: Class II Product Code: CGA, NBW, JJX Dated: April 19, 2012 Received: April 23, 2012

Dear Mr. Shen:

We have reviewed your Section $5 1 0 ( \mathbf k )$ premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).

Page 2

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (301) 796-5450. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21 CFR Part 807.97). For questions regarding postmarket surveillance, please contact CDRH's Office of Surveillance and Biometric's (OSB's) Division of Postmarket Surveillance at (301) 796-5760. For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/Medical   
Devices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance...

You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-5680 or at its Internet address http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm

Sincerely yours,

2L

Couptney H. Lias, Ph.D.   
Director   
Division of Chemistry and Toxicology Devices Office of In Vitro Diagnostic Device   
Evaluation and Safety   
Center for Devices and Radiological Health

# Indications for Use

510(k) Number: _k103230

Device Name: AP-3000 Blood Glucose Monitoring System

Indications for Use:

T A-0 Bloo GlucoMonirysenequanativeaument gu p thhor  testg y perns wihiabete t home.TheA-30 Blood Guco MonirigSsts is and is not intended for use on neonates.

Tpi e p uhih perons with diabetes at home. AP-3000 Blood Glucose Test Strips must be used with the AP-3000 Meter. The an should only be used by a sg patient as an d tomonior the effetivenessofdibee contrlt s inened to be used y a igle person and should not be hared. It is not intended for the diagnosis screening for diabetes mellitus, and is not intended for use on neonates.

T  Blo Gevu ti y per ith bete  om-3000 BlooGuco et Strips must e sedhe -Bo Glucoe Meter. The AP-30o Blood Glucose Test Strips areintended or testig outside the body nviro io u h not intendd or the diagnosis o or sreening or dabetes mellitus, and is not intended or se on neoaes.

MAJOR Lvel /Lve  Cn Soun oe wi-300ean -300 Bloo Guc  s quality control check to verify the accuracy of blood glucose test results.

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

# Indications for Use

510(k) Number: _k103230

Device Name: AP-300Omutli Blood Glucose Monitoring System

Indications for Use:

The AP-3o0multi Blood Glucose Monitoring System is intended for use in the quantitative measurement o pi  i a a n thig  st pers wibee- Blo Gucoiys hea et  n nor heeens  becntrol Thstsus and is not intended for use on neonates.

Th uMeatimnp persons with diabetes. AP-3000multi Blood Glucose Test Strips must be used with the AP-3000multi Meter. AP-30multi Meter is intended or testing outside the body in vito diagnostic use). It is intended for ua salt screening for diabetes mellitus, and is not intended for use on neonates.

The AP-0mulBlooGlucosTest ris  tene r he quanttativearement glu p hbl  e  o reestg y pers with iabetes-0u Blood GucosTet Strips ust eused wihe AuMeteAP-00uBloo Glucoe Test Strips eteneor testutsdehe body a intended for the diagnosis of or screening for diabetes mellitus, and is not intended for use on neonates.

MAJOR Level I/Level I Contro Solutions or use with AP-30multmeteranAP-3000mul Blood Gluco Test Strips as a quality control check to verify the accuracy of blood glucose test results.

Prescription Use_V And/Or Over the Counter Use_V (21 CFR Part 801 Subpart D) (21 CFR Part 801 Subpart C) (PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)

![](images/95f4ddd4244c316e070ee0ca9ac1f931fad123db1af0844262f5e84f43007920.jpg)

Division Sign-Off   
Office of In Vitro Diagnostic Device   
Evaluation and Safety

510(k) k103230